Qualia Oto develops shape-changing polymers and multiplexed thin-film transistor (TFT) electrode arrays for cochlear implants, enhancing biocompatibility and minimizing tissue trauma during implantation. Their technology addresses the limitations of conventional cochlear implants by providing precise auditory nerve stimulation and improved drug delivery to the inner ear.
Funding
$1.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Conventional cochlear implants, which rely on bundled wires, can cause tissue trauma during implantation and lack the precision needed for optimal auditory nerve stimulation and targeted drug delivery. Current devices also have limited biocompatibility, potentially leading to scarring and reduced long-term efficacy.
Solution
Qualia Oto is developing next-generation cochlear implants using shape-changing polymers and multiplexed thin-film transistor (TFT) electrode arrays to address the limitations of existing technology. The shape-changing polymers are initially stiff for reliable surgical implantation but soften at body temperature to minimize tissue trauma and scarring. The multiplexed TFT arrays enable precise auditory nerve stimulation and facilitate targeted drug delivery to the inner ear. This approach allows for a higher density of electrodes and integration with active electronic components for advanced, machine learning-based stimulation strategies.
Target Audience
The primary target audience includes individuals with disabling hearing loss who are candidates for cochlear implants, as well as ENT surgeons and audiologists seeking advanced solutions for auditory rehabilitation.
Features
- Shape-changing polymers that soften at body temperature to reduce tissue trauma during implantation
- Multiplexed TFT electrode arrays for precise auditory nerve stimulation
- Microfabricated arrays with a high density of electrodes and integrated active electronic components
- Potential for integration with machine learning-based stimulation strategies
- Dissolvable microtips for targeted drug delivery to the middle and inner ear with micron-level precision
- Demonstrated biocompatibility of polymers